BALCHEM CORP·4/A

Apr 11, 6:18 PM ET

Backus William A. 4/A

4/A · BALCHEM CORP · Filed Apr 11, 2025

Insider Transaction Report

Form 4/AAmended
Period: 2025-02-12
Backus William A.
VP & Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2025-02-13+2,0677,295 total
  • Award

    Common Stock

    2025-02-12+5505,228 total
  • Tax Payment

    Common Stock

    2025-02-13$163.14/sh1,073$175,0496,222 total
  • Award

    Stock Option

    2025-02-12+1,8001,800 total
    Exercise: $159.18Exp: 2035-02-12Common Stock (1,800 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    172
Footnotes (4)
  • [F1]Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
  • [F2]Represents the vesting of performance stock units (includes 34 dividend equivalent shares) for the 2022-2024 performance period.
  • [F3]1,073 of the 2,067 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
  • [F4]Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Documents

1 file
  • 4
    form4.xml

    FORM 4/A